– FRANCE, Strasbourg – Dynacure, a clinical-stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced the close of a €50 million Series C financing led by Perceptive Advisors alongside new investors participating including Bpifrance Large Venture and funds managed by Tekla Capital Management LLC.…
– FRANCE, Montrouge – Qarnot Computing today announced that a syndicate of investors including Banque des Territoires, Caisse des Dépôts, Engie Rassembleur d’Énergies, A/O PropTech, and Groupe Casino, have invested €6 million in the company.…
– FRANCE, Toulouse – Latécoère (EPA: LAT) today announced that its Board of Directors decided to reorganize the governance of the Group with immediate effect.…
– FRANCE, Nîmes – Advicenne (EPA: ADVIC), a specialty pharmaceutical company focused on the development and commercialization of therapeutic products for orphan renal and neurological diseases, today announced that Dr Luc-André Granier has left his role as CEO of the Company and that the Board of Directors has elected Dr André Ulmann, current Board Observer of the company, as Interim CEO of Advicenne, effective immediately.
– FRANCE, Vertou – Maisons du Monde (EPA: MDM) today announced that its Board of Directors co-opted Peter Child as an independent member and Chairman of the Board, succeeding Sir Ian Cheshire.…